Can hepatitis b be treated in new born babies

Hepatitis B (HBV) is a serious viral infection that can cause liver damage and liver cancer. In newborn babies, HBV infection can be particularly severe and potentially life-threatening if left untreated.

Fortunately, HBV can be treated in newborn babies, and the treatment is usually effective in preventing long-term complications. Here are some ways HBV can be treated in newborn babies:

  1. Antiviral medication: Infants born to mothers with HBV can receive antiviral medication, such as lamivudine or tenofovir, within 12 hours of birth. This medication can reduce the risk of transmission and prevent severe liver damage.
  2. Passive immunization: In addition to antiviral medication, newborn babies can receive passive immunization with hepatitis B immune globulin (HBIG) within 12 hours of birth. HBIG provides immediate protection against HBV infection.
  3. Vaccination: After receiving HBIG, newborn babies should receive the first dose of the hepatitis B vaccine at birth, followed by additional doses at 1-2 months and 6-18 months of age. This vaccination series is highly effective in preventing HBV infection.
  4. Monitoring and treatment: Babies born to mothers with HBV should be closely monitored for signs of liver damage or failure. If liver damage occurs, treatment may include antiviral medication, liver transplantation, or other interventions.

The American Academy of Pediatrics (AAP) recommends the following treatment approach for newborn babies born to mothers with HBV:

It's essential to note that early detection and treatment of HBV in newborn babies can significantly reduce the risk of long-term complications, such as liver cancer and liver failure. If you have concerns about HBV or your baby's treatment, consult with your healthcare provider.